Our team sends greetings and impressions from the Big Apple!
As we approach the final stretch of DCAT Week 2025 in New York, we reflect on an incredibly successful event so far! The Tiefenbacher Group team has had the privilege of engaging in insightful conversations, strengthening partnerships, and showcasing our latest innovations to make pharmaceuticals more affordable, more available, and better than ever before.
The dynamic atmosphere here in New York has been truly inspiring, and we are grateful for the many valuable exchanges with industry leaders and experts. As we head into the last day, we look forward to more meaningful discussions and new opportunities!
The DCAT Week in New York
For over 130 years, DCAT has provided a lifelong collegial community for its member companies and their representatives. It fosters relationships within its unique member company profile, encompassing the entire manufacturing value chain of the Bio/Pharmaceutical industry. DCAT offers objective, expert-driven educational programs and informational services, enabling its companies to gain insights into industry market trends, best practices, and the issues affecting the industry.

About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com